Enamine Ltd. has expanded its drug discovery collaboration with Actelion Pharmaceuticals to provide library synthesis and medicinal chemistry services for the synthesis of advanced screening compound libraries focused on therapeutic areas including: cardiovascular and central nervous system disorders, immunology, infectious diseases and oncology.   The companies have also entered a separate research contract, whereby Enamine will actively support Actelion’s medicinal chemistry efforts. The Ena...